A population-based study of risk factors for drug-resistant TB in British Columbia

International Journal of Tuberculosis and Lung Disease

Volumn 10, Issue 6, 2006, Pages 631-638

  Moniruzzaman, Akm ^a,b   Elwood, R K ^b   Schulzer, M ^a,c   FitzGerald, J M ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^c Centre for Clinical Epidemiology and Evaluation   (Canada)

Author keywords

Drug resistant tuberculosis; Multidrug resistant TB; Polyresistant TB; Population study; Risk factors

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CANADA; CHILD; CONTROLLED STUDY; ETHNOLOGY; FEMALE; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRITISH COLUMBIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 33744901703     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lienhardt C, Ogden J A. Tuberculosis control in resource-poor countries: have we reached the limits of the universal paradigm? Trop Med Int Health 2004; 9: 833-841.
2. Long R. Drug-resistant tuberculosis. Can Med Assoc J 2000; 163: 425-428.
3. Manns B J, Fanning E A, Cowie R L. Antituberculosis drug resistance in immigrants to Alberta, Canada, with tuberculosis, 1982-1994. Int J Tuberc Lung Dis 1997; 1: 225-230.
4. Dye C, Espinal M A, Watt C J, Mbiaga C, Williams B G. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002; 185: 1197-1202.
5. Pablos-Mendez A, Raviglione M C, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization- International Union Against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 1998; 338: 1641-1649.
6. Pritchard A J, Hayward A C, Monk P N, Neal K R. Risk factors for drug resistant tuberculosis in Leicestershire-poor adherence to treatment remain an important cause of resistance. Epidemiol Infect 2003; 130: 481-483.
7. Bloch A B, Cauthen G M, Onorato I M, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994; 271: 665-671.
8. Long R, Fanning A, Cowie R, et al. Antituberculous drug resistance in western Canada (1993 to 1994). Can Respir J 1997; 4: 71-75.
9. Farzad E, Holton D, Long R, et al. Drug resistance study of Mycobacterium tuberculosis in Canada, February 1, 1993 to January 31, 1994. Can J Public Health 2000; 91: 366-370.
10. Long R, Manfreda J, Mendella L, Wolfe J, Parker S, Hershfield E. Antituberculous drug resistance in Manitoba from 1980 to 1989. Can Med Assoc J 1993; 148: 1489-1495.
11. Scalcini M, Carre G, Jean-Baptiste M, et al. Antituberculous drug resistance in central Haiti. Am Rev Respir Dis 1990; 142: 508-511.
12. Taylor J P, Bergmire-Sweat D, Suarez L. Epidemiology of drug-resistant tuberculosis in Texas. Am J Epidemiol 1999; 149: 359-365.
13. Djuretic T, Herbert J, Drobniewski F, et al. Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax 2002; 57: 477-482.
14. Borchardt J, Kirsten D, Jorres R, Kroeger C, Magnussen H. Drug-resistant tuberculosis in northern Germany: a retrospective hospital-based study of 1,055 patients from 1984 until 1993. Eur Respir J 1995; 8: 1076-1083.
15. Elwood R K. 'TB in BC-who gets it?' BC Med J 2002; 44: 493.
16. FitzGerald J M, Wang L, Elwood R K. Tuberculosis: 13. Control of the disease among aboriginal people in Canada. Can Med Assoc J 2000; 162: 351-355.
17. Wang L, Noertjojo K, Elwood R K, FitzGerald J M. Factors affecting the decline in rates of tuberculosis among aboriginal persons in British Columbia. [Abstract] Int J Tuberc Lung Dis 1998; 2 (Suppl 1): S149.
18. Wang J S, Allen E A, Chao C W, Enarson D, Grzybowski S. Tuberculosis in British Columbia among immigrants in five Asian countries, 1982-1985. Tubercle 1989; 70: 179-186.
19. Centers for Disease Control. Primary resistance to antituberculous drugs-United States. MMWR 1983; 32: 521-523.
20. Alrajhi A A, Abdulwahab S, Almodover E, Al-Abdely H M. Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia. Saudi Med J 2002; 23: 305-310.
21. Keane V P, N de Klerk, Krieng T, Hammond G, Musk A W. Risk factors for the development of non-response to first-line treatment for tuberculosis in southern Vietnam. Int J Epidemiol 1997; 26: 1115-1120.
22. Helbling P, Altpeter E, Raeber P-A, Pfyffer G E, Zellweger J-P. Surveillance of antituberculosis drug resistance in Switzerland 1995-1997: the central link. Eur Respir J 2000; 16: 200-202.
23. Schaberg T, Gloger G, Reichert B, Mauch H, Lode H. Drug-resistant pulmonary tuberculosis in Berlin, Germany, 1987-1993. Eur Respir J 1995; 8: 278-284.